Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer Metastatic to Brain”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00002708
What this trial is testing

Radiation Therapy With or Without Radiosurgery in Treating Patients With Brain Metastases

Who this might be right for
Metastatic Cancer
Radiation Therapy Oncology Group 333
Testing effectiveness (Phase 2)Looking for participantsNCT06764940
What this trial is testing

A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases

Who this might be right for
HER2-negative Breast Cancer Patients With Brain Metastases
Biostar Pharma, Inc. 120
Testing effectiveness (Phase 2)Ended earlyNCT04610684
What this trial is testing

Chemotherapy and Atezolizumab for Patients With Extensive Stage Small Cell Lung Cancer (SCLC) With Untreated, Asymptomatic Brain Metastases

Who this might be right for
Small-cell Lung CancerBrain Metastases
Jeffrey Clarke 3
Not applicableStudy completedNCT00928226
What this trial is testing

Study of Fractionated Stereotactic Radiosurgery to Treat Large Brain Metastases

Who this might be right for
Brain CancerNeoplasm MetastasisCancer of Brain and Nervous System+1 more
Stanford University 56
Testing effectiveness (Phase 2)UnknownNCT01763385
What this trial is testing

Erlotinib With Concurrent Brain Radiotherapy and Secondary Brain Radiotherapy After Recurrence With Erlotinib in NSCLC Non-increased-intracranial-pressure Symptomatic Brain Metastases

Who this might be right for
Non-small-cell Lung CancerBrain Metastases
Wu Jieping Medical Foundation 210
Not applicableWithdrawnNCT00184288
What this trial is testing

Proton MR Spectroscopy of Brain Metastases in Evaluation of Treatment Response.

Who this might be right for
Neoplasm MetastasisLung NeoplasmsBreast Neoplasms+1 more
Norwegian University of Science and Technology
Not applicableStudy completedNCT02392078
What this trial is testing

Laser Ablation of Abnormal Neurological Tissue Using Robotic NeuroBlate System

Who this might be right for
Metastatic Brain TumorPrimary Brain TumorEpileptic/Seizure Foci+1 more
Monteris Medical 1,153
Testing effectiveness (Phase 2)Ended earlyNCT03728465
What this trial is testing

Evaluation of Safety and Efficacy of Patients With Four and More Symptomatic Brain Metastases of Melanoma

Who this might be right for
Metastatic MelanomaBrain Metastases
University Hospital Tuebingen 6
Testing effectiveness (Phase 2)UnknownNCT00107367
What this trial is testing

Radiation Therapy in Treating Patients Who Are Undergoing Surgery to Remove a Metastatic Brain Tumor

Who this might be right for
Metastatic Cancer
The Cleveland Clinic 62
Early research (Phase 1)Active Not RecruitingNCT02015117
What this trial is testing

Trametinib With or Without Whole Brain Radiation Therapy in Treating Patients With Brain Metastases

Who this might be right for
Metastatic Malignant Neoplasm in the Brain
National Cancer Institute (NCI) 10
Testing effectiveness (Phase 2)Looking for participantsNCT05584267
What this trial is testing

Immune Treatment of Brain Metastasis of Lung Cancer Combined With Large-segmentation Precision Radiotherapy

Who this might be right for
Non Small Cell Lung Cancer
Hunan Province Tumor Hospital 140
Testing effectiveness (Phase 2)Ended earlyNCT01978236
What this trial is testing

Dabrafenib/Trametinib, BRAF or BRAF AND MEK Pre-op With BRAF and MEK Post-op, Phase IIB, Melanoma With Brain Mets,Biomarkers and Metabolites

Who this might be right for
Melanoma and Brain Metastases
GlaxoSmithKline 6
Testing effectiveness (Phase 2)Study completedNCT04420598
What this trial is testing

DS-8201a for trEatment of aBc, BRain Mets, And Her2[+] Disease

Who this might be right for
Advanced Breast CancerHER2-positive Breast CancerBrain Metastases+1 more
MedSIR 41
Testing effectiveness (Phase 2)WithdrawnNCT05620914
What this trial is testing

A Window of Opportunity Study of Patritumab Deruxtecan in Patients With Brain Metastases

Who this might be right for
Brain Metastases, Adult
Mustafa Khasraw, MBChB, MD, FRCP, FRACP
Testing effectiveness (Phase 2)Ended earlyNCT00717275
What this trial is testing

Study of Temozolomide to Treat Newly Diagnosed Brain Metastases

Who this might be right for
Brain Metastases
University of Florida 3
Not applicableUnknownNCT03029065
What this trial is testing

Detection of CSF Next Generation Sequencing in the Application of Brain Metastases From Lung Adenocarcinoma or Meningeal Metastasis

Who this might be right for
Recruitment
Shandong Cancer Hospital and Institute 50
Large-scale testing (Phase 3)UnknownNCT01782287
What this trial is testing

Proteome-based Immunotherapy of Lung Cancer Brain Metastases

Who this might be right for
Neoplasm Metastasis
NeuroVita Clinic 60
Large-scale testing (Phase 3)UnknownNCT05104281
What this trial is testing

Osimertinib Combined With Bevacizumab in Patients With Brain Metastasis Epidermal Growth Factor Receptor (EGFR) Mutation Positive Metastatic Non-Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Qingdao Central Hospital 60
Testing effectiveness (Phase 2)Looking for participantsNCT05700721
What this trial is testing

Phase II Trial of the PARP Inhibitor Niraparib and PD-1 Inhibitor Dostarlimab in Patients With Advanced Cancers With Active Progressing Brain Metastases (STARLET)

Who this might be right for
Brain Metastases
M.D. Anderson Cancer Center 120
Testing effectiveness (Phase 2)Study completedNCT00587964
What this trial is testing

Phase II Trial of Stereotactic Radiosurgery Boost Following Surgical Resection for Brain Metastases

Who this might be right for
Brain MetastasisBladder CancerBreast Cancer+10 more
Memorial Sloan Kettering Cancer Center 51
Next Page